Further, future studies are needed to identify the mechanisms behind this differential weight loss response, the researchers wrote
Conversely, VLEKT, which induces nutritional ketosis, may be more appropriate for patients with significant cardiometabolic comorbidities, offering rapid and substantial fat mass reduction and improved glycaemic control
top selling glp1 drugs Market Scope and Assumptions The GLP-1 (Glucagon-Like Peptide-1) receptor agonist market is currently experiencing unprecedented growth, primarily driven by its dual application in Type 2 Diabetes and chronic weight management (obesity) YahooGrandviewresearch
10.1210/jendso/bvad114.712 82
Unlike Ozempic or Wegovy, Mounjaro targets two different hunger signals in the body (GLP-1 and GIP)
Ethics declarations Competing interests The authors declare no competing interests